Modified vaccinia virus ankara for the vaccination of neonates Grant US-8372622-B2 United States of America 12 Feb 2013
Modified Vaccinia Virus Ankara for the vaccination of neonates Grant US-8163293-B2 United States of America 24 Apr 2012
VACCINIA VIRUS MUTANTS CONTAINING THE MAJOR GENOMIC DELETIONS OF MVA Application WO-2011092029-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2011
MHC class I peptide epitopes from the human 5T4 tumor-associated antigen Grant US-7888115-B2 United States of America 15 Feb 2011
Mhc class I and II peptide antigens derived from tumour antigen 5t4 Application EP-2277918-A2 European Patent Office 26 Jan 2011
Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-assoc… Grant US-7575916-B2 United States of America 18 Aug 2009
Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigens Grant US-7541044-B2 United States of America 02 Jun 2009
Methods and reagents for vaccination which generate a CD8 T cell immune response Application EP-2058399-A1 European Patent Office 13 May 2009
Mhc class I and II peptide antigens derived from tumour antigen 5t4 Application EP-2045268-A1 European Patent Office 08 Apr 2009
5T4 tumour-associated antigen for use in tumour immunotherapy Application EP-2042598-A1 European Patent Office 01 Apr 2009
Recombinant Poxvirus-Cytomegalovirus Compositions and uses Application EP-1925662-A1 European Patent Office 28 May 2008
Genetic engineering; gene insertion; culture product Grant US-7198934-B2 United States of America 03 Apr 2007
RECOMBINANT VECTORS BASED ON THE MODIFIED VACCINIA ANKARA (MVA) VIRUS AS VACCINES AGAINST… Application WO-2007014977-A1 World Intellectual Property Organisation (WIPO) 08 Feb 2007
Poxvirus-rabies recombinants and compositions and methods employing the recombinants Grant US-7144578-B2 United States of America 05 Dec 2006
EXPRESSING FOREIGN GENES INSERTED AT SITE OF NATURALLY OCCURRING DELETION IN MODIFIED… Grant US-6440422-B1 United States of America 27 Aug 2002
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and… Grant US-6309647-B1 United States of America 30 Oct 2001
Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen Grant US-6265189-B1 United States of America 24 Jul 2001
Direct molecular cloning of foreign genes into poxviruses and methods for the preparation… Grant US-6265183-B1 United States of America 24 Jul 2001
CONTAINING A HETEROLOGOUS INSERT ENCODING AN IMMUNOGENIC PROTEIN, WHEREIN SAID INSERT WAS… Grant US-6103244-A United States of America 15 Aug 2000
Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor Grant US-6017542-A United States of America 25 Jan 2000
Recombinant poxvirus compositions and methods of inducing immune responses Grant US-5942235-A United States of America 24 Aug 1999
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence Grant US-5833975-A United States of America 10 Nov 1998
Trova fowl pox virus recombinants comprising heterologous inserts Grant US-5766599-A United States of America 16 Jun 1998
Modified recombinant vaccinia virus and expression vectors thereof Grant US-5762938-A United States of America 09 Jun 1998
Alvac canarypox virus recombinants comprising heterlogous inserts Grant US-5756103-A United States of America 26 May 1998
Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing… Grant US-5756102-A United States of America 26 May 1998
Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD and uses therefor Grant US-5688920-A United States of America 18 Nov 1997
NYVAC vaccinia virus recombinants comprising heterologous inserts Grant US-5494807-A United States of America 27 Feb 1996
Recombinant poxvirus host range selection system Grant US-5453364-A United States of America 26 Sep 1995
Recombinant poxvirus host range selection system Grant US-5225336-A United States of America 06 Jul 1993